Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601)
China
· Delayed Price · Currency is CNY 19.13
-0.54 (-2.75%)
Nov 15, 2024, 3:04 PM CST
Shenzhen Kangtai Biological Products Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 3,020 | 3,467 | 3,129 | 3,650 | 2,259 | 1,942 | Upgrade
|
| Other Revenue | 10.9 | 10.9 | 28.11 | 2.33 | 2.32 | 0.97 | Upgrade
|
| Revenue | 3,031 | 3,477 | 3,157 | 3,652 | 2,261 | 1,943 | Upgrade
|
| Revenue Growth (YoY) | -0.84% | 10.14% | -13.55% | 61.51% | 16.36% | -3.65% | Upgrade
|
| Cost of Revenue | 645.5 | 655.29 | 775.09 | 1,148 | 247.14 | 176.46 | Upgrade
|
| Gross Profit | 2,386 | 2,822 | 2,382 | 2,504 | 2,014 | 1,767 | Upgrade
|
| Selling, General & Admin | 1,404 | 1,505 | 1,315 | 819.8 | 1,030 | 943.74 | Upgrade
|
| Research & Development | 454.02 | 500.75 | 801.86 | 354.26 | 267.06 | 198.26 | Upgrade
|
| Other Operating Expenses | 146.19 | 25.62 | 20.49 | 20.16 | 14.46 | 10.31 | Upgrade
|
| Operating Expenses | 2,016 | 2,044 | 2,177 | 1,204 | 1,332 | 1,156 | Upgrade
|
| Operating Income | 370.08 | 778.26 | 205.13 | 1,300 | 682.04 | 610.46 | Upgrade
|
| Interest Expense | -122.91 | -113.71 | -108.97 | -54.51 | -2.34 | -8.93 | Upgrade
|
| Interest & Investment Income | 105.23 | 117.32 | 133.57 | 144.63 | 37.74 | 10.52 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | -1.82 | -0.35 | -0.01 | 0.09 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.98 | -0.65 | -0.52 | -4.19 | -0.47 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 355.38 | 781.22 | 227.38 | 1,386 | 716.96 | 612.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.01 | 0.19 | 3.18 | - | 30.14 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.43 | -1.35 | 0.13 | 0.03 | -0.29 | -0.19 | Upgrade
|
| Asset Writedown | -63.93 | -3.32 | -624.09 | -3.41 | -5.46 | -0.3 | Upgrade
|
| Other Unusual Items | 218.75 | 163.57 | 55.15 | 56.78 | 31.06 | 51.86 | Upgrade
|
| Pretax Income | 509.78 | 940.32 | -338.25 | 1,439 | 772.41 | 663.45 | Upgrade
|
| Income Tax Expense | -5.55 | 79.02 | -205.54 | 175.87 | 93.22 | 88.94 | Upgrade
|
| Net Income | 515.35 | 861.3 | -132.71 | 1,263 | 679.19 | 574.51 | Upgrade
|
| Net Income to Common | 515.35 | 861.3 | -132.71 | 1,263 | 679.19 | 574.51 | Upgrade
|
| Net Income Growth | 42.68% | - | - | 86.01% | 18.22% | 31.86% | Upgrade
|
| Shares Outstanding (Basic) | 1,125 | 1,119 | 1,106 | 1,093 | 1,055 | 1,010 | Upgrade
|
| Shares Outstanding (Diluted) | 1,125 | 1,119 | 1,106 | 1,111 | 1,076 | 1,021 | Upgrade
|
| Shares Change (YoY) | -14.89% | 1.15% | -0.43% | 3.24% | 5.34% | 2.56% | Upgrade
|
| EPS (Basic) | 0.46 | 0.77 | -0.12 | 1.16 | 0.64 | 0.57 | Upgrade
|
| EPS (Diluted) | 0.46 | 0.77 | -0.12 | 1.14 | 0.63 | 0.56 | Upgrade
|
| EPS Growth | 67.64% | - | - | 80.18% | 12.23% | 28.57% | Upgrade
|
| Free Cash Flow | 75.28 | 314.65 | -764.7 | -888.15 | -786.81 | 119.07 | Upgrade
|
| Free Cash Flow Per Share | 0.07 | 0.28 | -0.69 | -0.80 | -0.73 | 0.12 | Upgrade
|
| Dividend Per Share | 0.200 | 0.380 | - | 0.719 | 0.188 | - | Upgrade
|
| Dividend Growth | 11.11% | - | - | 283.36% | - | - | Upgrade
|
| Gross Margin | 78.70% | 81.16% | 75.45% | 68.57% | 89.07% | 90.92% | Upgrade
|
| Operating Margin | 12.21% | 22.38% | 6.50% | 35.60% | 30.16% | 31.41% | Upgrade
|
| Profit Margin | 17.00% | 24.77% | -4.20% | 34.59% | 30.04% | 29.56% | Upgrade
|
| Free Cash Flow Margin | 2.48% | 9.05% | -24.22% | -24.32% | -34.80% | 6.13% | Upgrade
|
| EBITDA | 561.22 | 973.61 | 406.08 | 1,705 | 774.97 | 693.44 | Upgrade
|
| EBITDA Margin | 18.51% | 28.00% | 12.86% | 46.68% | 34.27% | 35.68% | Upgrade
|
| D&A For EBITDA | 191.14 | 195.34 | 200.95 | 404.71 | 92.93 | 82.98 | Upgrade
|
| EBIT | 370.08 | 778.26 | 205.13 | 1,300 | 682.04 | 610.46 | Upgrade
|
| EBIT Margin | 12.21% | 22.38% | 6.50% | 35.60% | 30.16% | 31.41% | Upgrade
|
| Effective Tax Rate | - | 8.40% | - | 12.22% | 12.07% | 13.41% | Upgrade
|
| Revenue as Reported | 3,031 | 3,477 | 3,157 | 3,652 | 2,261 | 1,943 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 3.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.